Market Research Logo

Analysis of Alnylam Pharmaceuticals

Analysis of Alnylam Pharmaceuticals

Based in the United States, biopharmaceutical company Alnylam Pharmaceuticals is developing therapies on the foundation of ribonucleic acid interface (RNAi). The company wants to use the ribonucleic acid interface (RNAi) for the treatment of genetically defined diseases.

Aruvian’s R’search presents Analysis of Alnylam Pharmaceuticals. A complete and comprehensive analysis of Alnylam Pharmaceuticals, includes an overview of the industry the company operates in, a PEST Framework Analysis of the industry, and then moves on to analyzing the company itself.

Company analysis from Aruvians includes a history of Alnylam Pharmaceuticals, a business segment analysis of the segments Alnylam Pharmaceuticals operates through, a look at the organization structure of the company, a geographical operating segments analysis, an analysis of the company’s major competitors.

A financial analysis of Alnylam Pharmaceuticals is presented in the report which includes a ratio analysis, basic profit and loss analysis, presentation of the company balance sheet, and much more.

A SWOT Framework Analysis of Alnylam Pharmaceuticals completes this in-depth company analysis.


A. Executive Summary
B. Looking at the Industry
B.1 Industry Definition
B.2 Brief Profile of the Industry
B.3 Impacts on the Industry
B.4 Challenges Facing the Industry
B.5 Future Perspective
C. Industry PEST Framework Analysis
C.1 Political Aspects
C.2 Economic Aspects
C.3 Social Aspects
C.4 Technological Aspects
D. Looking at Alnylam Pharmaceuticals
D.1 Company Profile
D.2 History of the Company
D.3 Ownership Pattern in the Company
D.3.1 Major Holders
D.3.2 Major Direct Holders
D.3.3 Top Institutional Holders
D.3.4 Top Mutual Fund Holders
D.4 Organizational Divisions
D.5 Profiling the Key Executives
D.6 Products & Services
E. Looking at Business
E.1 Business Segments
E.2 Geographical Segments
E.3 Company Subsidiaries
F. SWOT Framework Analysis
F.1 Strengths to Build Upon
F.2 Weaknesses to Overcome
F.3 Opportunities to Exploit
F.4 Threats to Overcome
G. Profiling the Competition
G.1 Marina Biotech, Inc.
G.1.1 Corporate Profile
G.1.2 Business Segments Analysis
G.1.3 Financial Analysis
G.1.4 SWOT Analysis
G.2 Tekmira Pharmaceuticals Corporation
G.2.1 Corporate Profile
G.2.2 Business Segment Analysis
G.2.3 Financial Analysis
G.2.4 SWOT Analysis
G.3 Valeant Pharmaceuticals International, Inc.
G.3.1 Corporate Profile
G.3.2 Business Segment Analysis
G.3.3 Financial Analysis
G.3.4 SWOT Analysis
H. Financial Analysis of Alnylam Pharmaceuticals
H.1 Current Financials
H.2 Balance Sheet
H.3 Profit & Loss Statement
H.4 Ratio Analysis
H.4.1 Capital Market Ratios
H.4.2 Annual Ratios
H.4.3 Quarterly Ratios
I. Future Perspective
J. Glossary of Terms

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report